India's humanoid robots library · Specs, prices, news and buying guides - no hype.
RobotWale
Applications Elder-Care Robots Hands-on coverage

Elder-Care Robots: Shipping Hardware, Pilot Deployments, and the India Market Reality

📅 Published ⏰ 7 min read 👤 By RobotWale Editors
Portrait of a woman with a prosthetic arm wearing a black shirt. Studio lighting.
Summary A grounded assessment of ElliQ, Paro, Lovot, and assistive home companions. Grading claims by shipping hardware first, pilot deployments second, and announcements last, with explicit notes on India availability, landed costs, and regulatory pathways.

Introduction

The elder-care robotics sector has moved past the era of conceptual renders and venture-capital-funded roadmaps. What remains on the market today are specialized assistive companions designed for loneliness mitigation, routine prompting, and low-level monitoring. At RobotWale, we grade hardware claims by a strict hierarchy: shipping units in consumer or care-facility hands rank first, clinical or operational pilot deployments rank second, and corporate announcements rank last. This article applies that framework to ElliQ, Paro, Lovot, and the broader category of assistive home companions, with specific attention to India availability, landed cost estimates, and service realities.

These devices are not humanoid giants. They are focused instruments. Paro is a haptic therapeutic seal. Lovot is a mobile emotional-bonding unit. ElliQ is a desktop AI assistant. Each addresses a different slice of elder-care logistics, and each carries distinct shipping, regulatory, and maintenance profiles. The following analysis separates verified deployments from marketing timelines.

Shipping Hardware: The Current Market Baseline

Paro Therapeutic Seal Robot

Paro, developed by Japan's National Institute of Advanced Industrial Science and Technology (AIST) and commercialized through Therobotics (formerly Seiyaku), is the most mature shipping unit in this category. The hardware ships as a complete medical-adjacent device with tactile sensors, auditory processing, and self-calibrating behavior algorithms. It requires no programming from caregivers; it responds to voice, touch, and environmental cues. Power is delivered via a dedicated charging cradle, and the outer shell is removable for washing.

Therobotics publishes clear deployment guidelines and clinical documentation. The device is FDA-registered for therapeutic use in senior care facilities and has been installed in thousands of units across North America, Europe, and Japan. Pricing is transparent in manufacturer channels: approximately USD 8,000 to 10,000 per unit for institutional procurement, with volume tiers for care networks. India availability is limited to parallel importers and medical device distributors. Landed cost estimates for Indian buyers, including customs duties, IGST, and freight, typically range between INR 11.5 lakh to INR 13.5 lakh per unit, depending on the distributor and import documentation. Maintenance requires specialized sensor calibration and shell replacement parts, which are sourced through authorized channels.

Lovot Companion Robot

Lovot, manufactured by Groove X, operates on a different premise: emotional reciprocity through mobility and expressive actuators. The robot ships with a charging stand, voice interaction modules, and a subscription-based software layer that personalizes responses over time. Groove X has been shipping Lovot units since 2018, with production scaling in Japan and selective distribution in North America. The hardware is fully assembled and tested before dispatch, with clear spec sheets detailing battery life, weight, and actuator limits.

Manufacturer pricing sits around USD 4,000 for the base hardware, with subscription fees for advanced AI features. India does not have an official Groove X distribution channel. Units enter through parallel import networks, and landed costs typically fall between INR 5.5 lakh and INR 6.5 lakh, excluding potential service or warranty gaps. The device is not classified as a medical device, which simplifies import documentation but removes regulatory oversight for clinical claims. Caregivers should note that Lovot's mobility depends on flat indoor surfaces, and its software ecosystem is optimized for Japanese and English voice inputs.

ElliQ Desktop Assistant

ElliQ, developed by Intuition Robotics, is a stationary desktop companion that ships with a charging dock, high-fidelity speakers, and a camera array for environmental awareness. Unlike mobile robots, ElliQ focuses on proactive prompting: medication reminders, social connection facilitation, and cognitive engagement exercises. Intuition Robotics has been shipping ElliQ to residential customers and senior living facilities in the United States and Europe since 2023. The hardware is fully assembled, with firmware updates delivered over secure Wi-Fi.

Manufacturer pricing is structured as a hardware purchase plus a monthly subscription for AI features and care-network integrations. India availability remains unconfirmed through official channels. Parallel import estimates place landed costs between INR 7.0 lakh and INR 8.5 lakh, depending on voltage conversion requirements and import duties. ElliQ's software relies on cloud-based AI models, which raises data residency questions for Indian buyers. The device is not marketed as a clinical tool, and its prompts are designed for lifestyle support rather than medical intervention.

Pilot Deployments and Clinical Validation

Shipping hardware does not automatically equate to proven outcomes. Pilot deployments provide the next layer of verification. Paro has the most extensive pilot record, with randomized controlled trials published in geriatric care journals demonstrating reduced agitation scores and improved social interaction in dementia patients. These pilots are conducted through care facility partnerships, not consumer trials. The data is peer-reviewed and accessible through academic databases.

Lovot pilots have focused on emotional engagement and routine adherence in independent-living seniors. Studies published by Groove X and partner universities show increased daily conversation metrics and reduced self-reported loneliness, though sample sizes remain modest and follow-up periods are short. ElliQ pilots emphasize proactive prompting and medication adherence. Intuition Robotics reports pilot results from senior living operators showing improved check-in compliance, but the data is proprietary and not independently audited. Caregivers should treat these pilot findings as supportive rather than conclusive.

Both Paro and Lovot require periodic sensor calibration and firmware updates. ElliQ relies on continuous cloud connectivity, which introduces latency and privacy considerations. None of these devices replace human caregivers. They are assistive layers, not substitutes.

Announcements and Roadmaps (Graded Last)

The elder-care robotics space generates frequent announcements about AI integration, multi-robot coordination, and expanded care-network partnerships. Groove X has announced plans for Lovot 2.0 with enhanced mobility and cross-device networking. Intuition Robotics has outlined roadmap features for ElliQ including advanced health-tracking integrations and caregiver dashboards. Therobotics has communicated updates to Paro's behavioral algorithms and sensor arrays. These announcements are real corporate commitments, but they rank last in our grading hierarchy. Until units ship with verified specifications and independent pilot data, they remain developmental timelines.

Indian buyers should note that announcement-driven purchases carry execution risk. Supply chain delays, regulatory approvals, and software localization often extend timelines. We recommend tracking shipping dates, distributor agreements, and pilot publications before committing capital.

India Availability and Landed Cost Estimates

India's elder-care robotics market is in early adoption. No official manufacturer channels exist for ElliQ, Lovot, or Paro. All units enter through medical device importers, parallel tech distributors, or care facility procurement networks. Landed cost estimates include freight, customs duties, IGST, and voltage conversion:

Regulatory considerations are critical. Paro's therapeutic claims may trigger CDSCO scrutiny if marketed as a medical device. Lovot and ElliQ are classified as consumer electronics or lifestyle aids, which simplifies import but limits clinical use cases. Service networks are fragmented. Indian buyers should secure distributor warranties, import documentation, and local technical support before purchase. Voltage conversion, firmware localization, and spare parts availability are recurring operational challenges.

Practical Assessment for Caregivers

Elder-care robots are practical tools when matched to specific needs. Paro suits facilities managing dementia-related agitation and seeking non-pharmacological interventions. Lovot works for independent seniors who respond to mobility and emotional feedback. ElliQ fits households requiring proactive prompting and routine tracking. None replace human care, and none solve systemic elder-care shortages. They reduce friction in daily logistics.

Indian buyers should prioritize verified shipping hardware, independent pilot data, and local service support. Announcements and roadmaps are useful for tracking industry direction but should not drive procurement decisions. The market is maturing, but grounded evaluation remains essential.

References

Key takeaways

References

  1. Therobotics Official Site
  2. Intuition Robotics ElliQ Product Page
  3. Groove X Lovot Official Information
  4. FDA Therapeutic Device Database
  5. CDSCO Medical Device Classification Guidelines
  6. Geriatric Care Pilot Publications (PubMed/PMC)
Editorial note Robot specs, release timelines and India prices shift quickly. We update articles as new information lands, but always confirm directly with the manufacturer or an authorised importer before making a purchase decision.

Get the weekly RobotWale brief

One short email a week. New humanoid launches, prices that actually matter in India, hands-on reviews and the research papers worth reading. No hype. No sponsored fluff.

Free. Unsubscribe any time. We will never share your email.

Browse the library